Seval Ay Ersoy - Haydarpasa Numune Research and Teaching Hospital

基本信息

浏览量：1

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 26 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Prognostic Significance of Mucinous Histology in Left‑sided Metastatic Colorectal Cancers with Wild‑type RAS and Evaluation of Backbone Chemotherapy Regimens

Rukiye Arikan,Muhammed Mustafa Atci,Seval Ay,Murat Ayhan,Nazim Can Demircan,Tugba Akin Telli,Abdussamet Celebi,Alper Yasar,Selver Isik,Cigdem Celikel,Ozlem Balvan,Ibrahim Vedat Bayoglu,Osman Kostek,Faysal Dane,Perran Fulden Yumuk

Oncology Lettersno. 5 (2023)

引用0浏览0WOS引用

Is Adipose Tissue Metabolic Activity a Predictor of Pathological Responses to Neoadjuvant Treatment in Breast Cancer

O. Dulgar,E. Orsal Ibisoglu,S. Ay,H. Uslu,M. Gumus

REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR（2023）

引用1浏览0WOS引用

Meme Kanserinde Neoadjuvan Kemoterapi Yanıtlarını Öngörmede Belirleyici Olarak Açlık Kan Şekeri Ve Vücut Kitle Indeksi

Özgecan DÜLGAR,Seval AY,Mahmut GÜMÜŞ

Anadolu Kliniği Tıp Bilimleri Dergisino. 1 (2023): 66-71

引用0浏览0引用

Prognostic Role of Hormone Status in Endometrium Cancer

Seval AY,Özgecan DÜLGAR,Hüseyin KANMAZ

Turkish Journal of Clinics and Laboratoryno. 3 (2022): 397-401

引用0浏览0引用

Is the Benefit of Using Adjuvant Capecitabine in Patients with Residual Triple-Negative Breast Cancer Related to Pathological Response to Neoadjuvant Chemotherapy

Ozgecan Dulgar,Basak Bala Oven,Muhammed Mustafa Atci,Rukiye Arikan,Seval Ay,Murat Ayhan,Oguzhan Selvi,Deniz Tataroglu Ozyukseler,Ertugrul Bayram,Erkan Ozcan,Ayse Irem Yasin,Mahmut Gumus

Expert Review of Anticancer Therapy（2022）

引用0浏览0WOS引用

FOLFIRINOX Versus Gemcitabine Plus Nab-Paclitaxel As the First-Line Chemotherapy in Metastatic Pancreatic Cancer

Seval Ay,Muhammed Mustafa Atci,Rukiye Arikan,Ozgecan Dulgar,Deniz Tataroglu Ozyukseler,Nail Paksoy,Izzet Dogan,Bugra Oztosun,Didem Tastekin,Basak Bala Oven,Mahmut Gumus

JOURNAL OF CHEMOTHERAPY（2022）

引用4浏览0WOS引用

The Predictive Importance of Body Mass Index on Response to Neoadjuvant Chemotherapy in Patients with Breast Cancer

Levent Emirzeoglu,Serdar Arici,Ahmet Bilgehan Sahin,Birol Ocak,Naziye Ak,Seval Ay,Elkhan Mammadov,Hande Turna,Ahmet Bilici

Breast care（2022）

引用0浏览0WOS引用

Second Line Treatment Choice in Extensive Small Lung Cancer

Seval Ay

Eurasian Journal of Medical Investigation (2022)

引用0浏览0引用

The Impact of Adjuvant Oxaliplatin and Tumor Sidedness on the Overall Survival of Stage IIB Colon Cancer Patients: a Multicentre Study

Muhammed Mustafa Atci,Baran Akagunduz,Metin Demir,Rukiye Arikan,Seval Ay,Muhammet Ozer,Murat Ayhan,Ibrahim Cil,Nazan Demir,Neslihan Ozyurt,Gokhan Karakaya,Gokcen Tugba Cevik,Arif Hakan Onder,Oguzhan Selvi,Abdullah Sakin

Journal of chemotherapy（2022）

引用0浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn